Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Mutonga

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Chest|January 10, 2025
A 75-Year-Old Man With Supine HypotensionAndres Leonardo Mora Carpio, Madelyn Renzetti, Martin Mutonga, et al.
Journal of Vascular and Interventional Radiology : JVIR|July 5, 2024
The Predictive Value of Qanadli and Miller Index Scores in Patients with Intermediate-High-Risk and High-Risk Pulmonary Emboli Undergoing Aspiration ThrombectomyAdam Fish, Elizabeth Knight, Martin Mutonga, et al.
Translational Oncology|October 27, 2015
Targeting Suppressor of Variegation 3-9 Homologue 2 (SUV39H2) in Acute Lymphoblastic Leukemia (ALL)Martin Mutonga, Kenji Tamura, Gregory Malnassy, et al.
Breast Cancer Research and Treatment|April 13, 2019
Relationship of pathological features and a 21 gene expression assay in younger versus older women with node-negative endocrine receptor-positive breast cancerMartin Mutonga, Sedona Speedy, Alfred Rademaker, et al.
BMC Nephrology|November 23, 2016
Quantitative characterization of T-cell repertoire and biomarkers in kidney transplant rejectionHouda Alachkar, Martin Mutonga, Taigo Kato, et al.
Cardiovascular and Interventional Radiology|February 16, 2024
An International Collaboration in Interventional Radiology Training: Cultivating Knowledge and Fostering Interest Among Radiology Residents in East AfricaBalowa Musa, Nader Ashraf, Anusha Gandhi, et al.
Journal of Vascular and Interventional Radiology : JVIR|March 5, 2025
Portal and Hepatic Vein Embolization versus Portal Venous Embolization Alone in Cirrhotic and Noncirrhotic Swine: A Pilot StudyJonathan Tefera, Tom N Kuhn, Nickolai J Matuschewski, et al.
Oncotarget|October 10, 2015
T-LAK cell-originated protein kinase presents a novel therapeutic target in FLT3-ITD mutated acute myeloid leukemiaHouda Alachkar, Martin Mutonga, Gregory Malnassy, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Chest|January 10, 2025
A 75-Year-Old Man With Supine HypotensionAndres Leonardo Mora Carpio, Madelyn Renzetti, Martin Mutonga, et al.
Journal of Vascular and Interventional Radiology : JVIR|July 5, 2024
The Predictive Value of Qanadli and Miller Index Scores in Patients with Intermediate-High-Risk and High-Risk Pulmonary Emboli Undergoing Aspiration ThrombectomyAdam Fish, Elizabeth Knight, Martin Mutonga, et al.
Translational Oncology|October 27, 2015
Targeting Suppressor of Variegation 3-9 Homologue 2 (SUV39H2) in Acute Lymphoblastic Leukemia (ALL)Martin Mutonga, Kenji Tamura, Gregory Malnassy, et al.
Breast Cancer Research and Treatment|April 13, 2019
Relationship of pathological features and a 21 gene expression assay in younger versus older women with node-negative endocrine receptor-positive breast cancerMartin Mutonga, Sedona Speedy, Alfred Rademaker, et al.
BMC Nephrology|November 23, 2016
Quantitative characterization of T-cell repertoire and biomarkers in kidney transplant rejectionHouda Alachkar, Martin Mutonga, Taigo Kato, et al.
Cardiovascular and Interventional Radiology|February 16, 2024
An International Collaboration in Interventional Radiology Training: Cultivating Knowledge and Fostering Interest Among Radiology Residents in East AfricaBalowa Musa, Nader Ashraf, Anusha Gandhi, et al.
Journal of Vascular and Interventional Radiology : JVIR|March 5, 2025
Portal and Hepatic Vein Embolization versus Portal Venous Embolization Alone in Cirrhotic and Noncirrhotic Swine: A Pilot StudyJonathan Tefera, Tom N Kuhn, Nickolai J Matuschewski, et al.
Oncotarget|October 10, 2015
T-LAK cell-originated protein kinase presents a novel therapeutic target in FLT3-ITD mutated acute myeloid leukemiaHouda Alachkar, Martin Mutonga, Gregory Malnassy, et al.
Pageof 1